Benn Abigail, Barker Gareth R I, Stuart Sarah A, Roloff Eva V L, Teschemacher Anja G, Warburton E Clea, Robinson Emma S J
School of Physiology, Pharmacology, and Neuroscience, Faculty of Biomedical Sciences, University of Bristol, Bristol BS8 1TD, United Kingdom
School of Physiology, Pharmacology, and Neuroscience, Faculty of Biomedical Sciences, University of Bristol, Bristol BS8 1TD, United Kingdom.
J Neurosci. 2016 May 4;36(18):4930-9. doi: 10.1523/JNEUROSCI.2933-15.2016.
Finding effective cognitive enhancers is a major health challenge; however, modulating glutamatergic neurotransmission has the potential to enhance performance in recognition memory tasks. Previous studies using glutamate receptor antagonists have revealed that the medial prefrontal cortex (mPFC) plays a central role in associative recognition memory. The present study investigates short-term recognition memory using optogenetics to target glutamatergic neurons within the rodent mPFC specifically. Selective stimulation of glutamatergic neurons during the online maintenance of information enhanced associative recognition memory in normal animals. This cognitive enhancing effect was replicated by local infusions of the AMPAkine CX516, but not CX546, which differ in their effects on EPSPs. This suggests that enhancing the amplitude, but not the duration, of excitatory synaptic currents improves memory performance. Increasing glutamate release through infusions of the mGluR7 presynaptic receptor antagonist MMPIP had no effect on performance.
These results provide new mechanistic information that could guide the targeting of future cognitive enhancers. Our work suggests that improved associative-recognition memory can be achieved by enhancing endogenous glutamatergic neuronal activity selectively using an optogenetic approach. We build on these observations to recapitulate this effect using drug treatments that enhance the amplitude of EPSPs; however, drugs that alter the duration of the EPSP or increase glutamate release lack efficacy. This suggests that both neural and temporal specificity are needed to achieve cognitive enhancement.
寻找有效的认知增强剂是一项重大的健康挑战;然而,调节谷氨酸能神经传递有可能提高识别记忆任务中的表现。以往使用谷氨酸受体拮抗剂的研究表明,内侧前额叶皮质(mPFC)在联想识别记忆中起核心作用。本研究使用光遗传学特异性地靶向啮齿动物mPFC内的谷氨酸能神经元来研究短期识别记忆。在信息的在线维持期间对谷氨酸能神经元进行选择性刺激可增强正常动物的联想识别记忆。这种认知增强作用可通过局部注射AMPA受体激动剂CX516复制,但注射CX546则不能,这两种药物对兴奋性突触后电位(EPSP)的作用不同。这表明增强兴奋性突触电流的幅度而非持续时间可改善记忆表现。通过注射代谢型谷氨酸受体7(mGluR7)突触前受体拮抗剂MMPIP来增加谷氨酸释放对表现没有影响。
这些结果提供了新的机制信息,可指导未来认知增强剂的靶向研究。我们的工作表明,使用光遗传学方法选择性增强内源性谷氨酸能神经元活动可改善联想识别记忆。我们基于这些观察结果,使用增强EPSP幅度的药物治疗来重现这种效果;然而,改变EPSP持续时间或增加谷氨酸释放的药物缺乏疗效。这表明实现认知增强需要神经特异性和时间特异性。